Xingyue An

5PUBLICATIONS
15CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 18, 2025
EVOLVE platform, a trispecific T cell engager with integrated CD2 costimulation, for the treatment of solid and hematologic tumors.

Oksana A Sergeeva, Guixian Jin, Mohosin Sarkar

|Aug 25, 2017
Single-cell profiling of dynamic cytokine secretion and the phenotype of immune cells.

Xingyue An, Victor G Sendra, Ivan Liadi

Pageof 1